Neurocrine Biosciences Inc (NASDAQ:NBIX)

85.25
Delayed Data
As of Feb 16
 -0.32 / -0.37%
Today’s Change
39.21
Today|||52-Week Range
91.82
+9.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues0.006.3M60.8M94.5M
 
 
 
 
Cost of Goods Sold0.0061.0K433.0K54.0K
 
 
 
 
Depreciation And Amortization489.0K589.0K616.0K706.0K
 
 
 
 
 
 
Operating ExpensesGross Income-489.0K5.7M59.7M93.8M
 
 
 
 
 
General Expenses79.4M63.0M65.7M81.9M
 
 
 
 
 
Research And Development51.9M21.9M22.5M25.6M
 
 
 
 
 
Total Operating Expenses79.9M63.6M66.8M82.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-79.9M-57.3M-6.0M11.8M
 
 
 
 
 
Interest Expense On Debt0.004.8M7.3M7.4M
 
 
 
 
Other Expenses879.0K881.0K188.0K156.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-78.3M-60.0M-11.1M6.9M
 
 
 
 
 
Net Income-78.3M-60.0M-11.1M6.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS87.3M88.1M88.3M88.7M
 
 
 
 
 
Shares To Calculate EPS Diluted87.3M88.1M88.3M92.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.90-$0.68-$0.13$0.07
 
 
 
 
 
EPS Diluted-$0.90-$0.68-$0.13$0.07